These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8262744)

  • 21. Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
    Bernardino ME; Young SW; Lee JK; Weinreb J
    Invest Radiol; 1991 Nov; 26 Suppl 1():S148-9; discussion S150-5. PubMed ID: 1808113
    [No Abstract]   [Full Text] [Related]  

  • 22. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MnDPDP as a negative hepatic contrast agent: evaluation of STIR imaging compared with T1-weighted SE and GE techniques.
    Halavaara JT; Lamminen AE
    J Comput Assist Tomogr; 1997; 21(1):94-9. PubMed ID: 9022776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
    Gehl HB; Urhahn R; Bohndorf K; Klever P; Hauptmann S; Lodemann KP; Matern S; Schumpelick V; Günther RW
    Radiology; 1993 Mar; 186(3):795-8. PubMed ID: 8430190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manganese-enhanced MRI of hypoxic-ischemic brain injuries using Mn-DPDP.
    Yang J; Wu EX
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():4775-8. PubMed ID: 19964849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
    Rofsky NM; Weinreb JC
    Magn Reson Q; 1992 Sep; 8(3):156-68. PubMed ID: 1390058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ; Kim MJ; Kim KW
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
    Bernardino ME; Young SW; Lee JK; Weinreb JC
    Radiology; 1992 Apr; 183(1):53-8. PubMed ID: 1549694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
    Slater GJ; Saini S; Mayo-smith WW; Sharma P; Eisenberg PJ; Hahn PF
    Clin Radiol; 1996 Jul; 51(7):484-6. PubMed ID: 8689823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of pancreas and diagnosis of pancreatitis using manganese dipyridoxyl diphosphate.
    Baba Y; Lerch MM; Tanimoto A; Kreft BP; Saluja AK; Zhao L; Chen J; Steer ML; Stark DD
    Invest Radiol; 1994 Jun; 29 Suppl 2():S300-1. PubMed ID: 7928263
    [No Abstract]   [Full Text] [Related]  

  • 32. Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
    Wang DB; Zhou KR; Zeng MS; Chen KM; Wang YX
    Eur Radiol; 2004 Apr; 14(4):743-5. PubMed ID: 12802614
    [No Abstract]   [Full Text] [Related]  

  • 33. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine.
    Gallez B; Baudelet C; Adline J; Charbon V; Lambert DM
    Magn Reson Imaging; 1996; 14(10):1191-5. PubMed ID: 9065910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal gland enhancement at MR imaging with Mn-DPDP.
    Mitchell DG; Outwater EK; Matteucci T; Rubin DL; Chezmar JL; Saini S
    Radiology; 1995 Mar; 194(3):783-7. PubMed ID: 7862979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients.
    Aicher KP; Laniado M; Kopp AF; Grönewäller E; Duda SH; Claussen CD
    J Magn Reson Imaging; 1993; 3(5):731-7. PubMed ID: 8400558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
    Gong J; Xu J; Zhou K; Shen K
    Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
    Suto Y; Weinreb JC; Rofski NM
    J Comput Assist Tomogr; 1996; 20(4):647-9. PubMed ID: 8708073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Mn-DPDP and manganese chloride on hemodynamics and glucose tolerance in anesthetized rats.
    Gao X; Sandberg M; Quach M; Bodin B; Johansson L; Jansson L
    Acta Radiol; 2014 Apr; 55(3):328-34. PubMed ID: 23963152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients.
    Rummeny E; Ehrenheim C; Gehl HB; Hamm B; Laniado M; Lodemann KP; Schmiedel E; Steudel A; Vogl TG
    Invest Radiol; 1991 Nov; 26 Suppl 1():S142-5; discussion S150-5. PubMed ID: 1808111
    [No Abstract]   [Full Text] [Related]  

  • 40. MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction.
    Leander P; Golman K; Klaveness J; Holtz E; Olsson M; Leunbach I
    Invest Radiol; 1990 Oct; 25(10):1130-4. PubMed ID: 2127772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.